<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(10)</volume><submitter>Crabol Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Optimal management of eumycetoma, a severely debilitating chronic progressive fungal infection of skin, disseminating to bone and viscera, remains challenging. Especially, optimal antifungal treatment and duration are ill defined.&lt;h4>Methodology/principal findings&lt;/h4>We conducted a monocentric retrospective study of 11 imported cases of eumycetoma treated by voriconazole or posaconazole for at least 6 months. Response to treatment was assessed through evolution of clinical and magnetic resonance imaging (MRI). (1→3) ß-D-glucan (BG) and positron emission tomography using [18F] fluorodeoxyglucose (PET/CT) results were also assessed. Identified species were Fusarium solani complex (n = 3); Madurella mycetomatis, (n = 3), and Exophiala jeanselmei, (n = 1). Moreover, two coe</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pagination>e3232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4191942</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Last generation triazoles for imported eumycetoma in eleven consecutive adults.</pubmed_title><pmcid>PMC4191942</pmcid><pubmed_authors>Barete S</pubmed_authors><pubmed_authors>Zeller V</pubmed_authors><pubmed_authors>Lecuit M</pubmed_authors><pubmed_authors>French Mycosis Study Group</pubmed_authors><pubmed_authors>Pineau S</pubmed_authors><pubmed_authors>Lanternier F</pubmed_authors><pubmed_authors>Poiree S</pubmed_authors><pubmed_authors>Amazzough K</pubmed_authors><pubmed_authors>Maunoury C</pubmed_authors><pubmed_authors>Crabol Y</pubmed_authors><pubmed_authors>Lortholary O</pubmed_authors><pubmed_authors>Bougnoux ME</pubmed_authors><pubmed_authors>Arvieux C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Last generation triazoles for imported eumycetoma in eleven consecutive adults.</name><description>&lt;h4>Background&lt;/h4>Optimal management of eumycetoma, a severely debilitating chronic progressive fungal infection of skin, disseminating to bone and viscera, remains challenging. Especially, optimal antifungal treatment and duration are ill defined.&lt;h4>Methodology/principal findings&lt;/h4>We conducted a monocentric retrospective study of 11 imported cases of eumycetoma treated by voriconazole or posaconazole for at least 6 months. Response to treatment was assessed through evolution of clinical and magnetic resonance imaging (MRI). (1→3) ß-D-glucan (BG) and positron emission tomography using [18F] fluorodeoxyglucose (PET/CT) results were also assessed. Identified species were Fusarium solani complex (n = 3); Madurella mycetomatis, (n = 3), and Exophiala jeanselmei, (n = 1). Moreover, two coe</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Oct</publication><modification>2025-04-03T21:34:16.496Z</modification><creation>2019-03-26T22:41:15Z</creation></dates><accession>S-EPMC4191942</accession><cross_references><pubmed>25299610</pubmed><doi>10.1371/journal.pntd.0003232</doi></cross_references></HashMap>